Outside of their preferred channel to engage and learn about new products, the types of information presented about new brands can also drive interest. Both Specialists and GPs suggest the most compelling information about new products are data showing efficacy in head to head trials and to a lesser extent placebo based comparisons, better tolerability and safety profiles, data demonstrating improved quality of life, more convenience as well as longer duration of action.
While GPs and Specialists share similar views on their preferred channels as well as the types of information they find compelling, they do differ in terms of when they prefer to learn about new products. While more than 8 in 10 GPs say they prefer to learn about new product once they are approved and / or they have access, just over half of Specialists say they want to know about new drugs during the clinical trial phase.
Creating interest and providing information that drives physicians to prescribe and recommend new products is a challenge but successful engagement that is tailored to what interests physicians through the channels they find most engaging can help ensure new brands succeed.